Clinical trials recruiting in Aix-en-Provence, France

Phase breakdown

Conditions recruiting in Aix-en-Provence, France

Recruiting trials in Aix-en-Provence, France

• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
  NCT05211895 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
  NCT07219173 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
  NCT06764693 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
  NCT05122806 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
  NCT06487078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years
  NCT05373940 · Phase: Not applicable (e.g. observational or device study) · Ages: 70 Years and older · Sex: All (male and female)
• Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.
  NCT07645872 · Phase: Not specified · Ages: No age limits stated · Sex: Male
• De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
  NCT05255302 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female)
• ENDOmetriosis Robotic Assisted Surgery
  NCT06445179 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• Educational Program for the Multidisciplinary Support of Patients With Endometriosis
  NCT07134023 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
  NCT05973201 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
  NCT06393816 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
  NCT06837454 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
  NCT07243132 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
  NCT07380711 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
  NCT07566195 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
  NCT07563205 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
  NCT06646471 · Phase: Phase 4 · Ages: 70 Years and older · Sex: All (male and female)
• Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
  NCT06552234 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
  NCT06207981 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Predictive Signature of Benralizumab Response
  NCT04565483 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
  NCT07234058 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
  NCT06726720 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Aix-en-Provence, France?

24 recruiting trials have at least one study site in Aix-en-Provence, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.